EBIT at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Plus components not separately reported this period.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's EBIT?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported EBIT of $29.27M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's EBIT changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's EBIT increased by 120.5% year-over-year, from $13.27M to $29.27M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's EBIT?
- Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's EBIT has grown at a -16.2% compound annual growth rate (CAGR), from -$156.64M to $77.22M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.